https://www.hemophiliafed.org/bioverativ-announces-results-of-eloctate-study-showing-high-bleed-protection-and-target-joint-resolution/
Bioverativ Announces Results of Eloctate Study Showing High Bleed Protection and Target Joint...
Dec 16, 2017 - Note: The following is edited from a press release from Bioverativ. Read the full press release in its entirety here. Bioverativ Inc. and Swedish Orphan...
bioverativannouncesresultseloctatestudy
https://salesandmarketingnetwork.com/news_release_bs.html?pipe=0000ac177000191&ID=2039156&key=factor+IX
News for Medical Sales Reps: Health Canada Approves Eloctate(TM), the First Therapy to Extend the...
sales repshealth canadathe firstnewsmedical